We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS

EMD Serono

Community Affairs Manager: Renee Connolly

Email: renee.connolly@emdserono.com

Telephone Number: 781-681-2471

Approved Drugs:

Serostim (somatotropin) - recombinant human growth hormone (rhGH) [wasting syndrome]

Drugs in Pre-approval Status:

1) Tesamorelin — growth hormone-releasing factor

Comment: Phase II and Phase III data presented and published. Approval anticipated third or fourth quarter, 2009 (to be sold and marketed in U.S. by EMD Serono; developed by Theratechnologies of Montreal).

Patient Assistance:

www.hivwasting.com

Co-payment Assistance:

www.hivwasting.com